Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now small index

Arthropathy of Knee clinical trials

3 of 7 indexed Arthropathy of Knee trials are currently recruiting.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

7 US clinical trials · 3 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Arthropathy of Knee: 7 US clinical trials tracked, 3 recruiting.

Arthropathy of Knee is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is Nicolas Noiseux, MD, MS, FRCSC, running 1 of these trials.

Enrollment posture brief

Registry condition arthropathy-of-knee

OPEN 3 | RECR 43% | LATE 0 | EARLY 0 | RANK #2497 | SPON 1

Nearest open-share peer: Adrenoleukodystrophy (43% recruiting · 7 trials)

ACL Tear71.4%ACL57.1%Arthropathy of Knee (this)43%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Arthropathy of Knee

Arthropathy of Knee lists 3 open slots (43% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Arthropathy of Knee on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Arthropathy of Knee is recruiting below its size-band peers.

    3 of 7 indexed trials (42.9%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Arthropathy of Knee trials is spread across many organizations.

    Nicolas Noiseux, MD, MS, FRCSC accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Most Arthropathy of Knee trials plan to enrol fewer than 100 people.

    Median target enrolment is 70 among the 7 trials that report a genuine target (sentinel values excluded). 5 of those (71.4%) plan for fewer than 100 participants.

  4. Arthropathy of Knee research is mostly interventional.

    7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Arthropathy of Knee records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

EPI100 group Drug
1 trials
EPI75 group Drug
1 trials
EPI50 group Drug
1 trials
EPI25 Drug
1 trials
Bupivacaine Only Drug
1 trials
Opioid education via video Other
1 trials
Opioid education in person Other
1 trials
White LED light therapy Device
1 trials

US sites by state

Facility locations filed on Arthropathy of Knee trials. A trial with sites in several states counts in each.

New York 2 trials
Texas 1 trials
South Carolina 1 trials
Pennsylvania 1 trials
Ohio 1 trials
North Carolina 1 trials
Michigan 1 trials
Iowa 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Arthropathy of Knee page

7 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Arthropathy of Knee condition card totals 7 registered trials; most-linked intervention EPI100 group; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.